Skip to content

Validation of a predictive model for postoperative delirium in elderly orthopedic patients

Validation of a predictive model for postoperative delirium in elderly orthopedic patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074738
Enrollment
Unknown
Registered
2023-08-15
Start date
2023-08-14
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Case series:none

Sponsors

Chun'an First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to 105 Years

Inclusion criteria

Inclusion criteria: 1) Lumbar and epidural anesthesia femur, tibia and fibula fracture, hip and knee replacement surgery 2) Combined epidural anesthesia 3) =75 years old 4) ASAI-III level 5) BMI1h 7) Length of hospital stay>72h 8) Postoperative unplanned sedation and unplanned admission to ICU

Exclusion criteria

Exclusion criteria: 1) Cognitive Summary Mental State Test (MMSE) score 6h, drug-induced delirium, alcohol withdrawal delirium. 3) Dementia, Parkinson's disease, delirium, seizure, stroke within 1 month, intracranial disease or intracranial surgery within 1 year. 4) Severe audio-visual impairment, mental illness. 5) Use atypical antipsychotics, cholinesterase related drugs, dopaminergics, benzodiazepines, steroids and melatonin drugs for a long time or nearly a week. 6) Intraoperative atropine dosage>2mg. 7) Use of postoperative delirium cluster nursing program. 8) Evidence of spinal injury, nerve damage, 9) Diabetes that requires insulin control, 10) Preoperative electrolyte disturbance, systemic inflammatory response syndrome, cancer, hemodialysis treatment within a week 11) Hypotension (mean arterial pressure100ml/ day) 13) There are contraindications or allergies to the drug in this study.

Design outcomes

Primary

MeasureTime frame
postoperative delirium;

Secondary

MeasureTime frame
interleukin-6;Neurofilament;Cholinesterase;transthyretin;

Countries

China

Contacts

Public ContactYiqi Fang

Chun'an First People's Hospital

491941234@qq.com+86 158 6913 2935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026